Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab or TAR-200 Alone Versus In
Sponsored by Janssen Research & Development, LLC
Active
$12.7K Funding
1 People
External
Related Topics
clinical trials,
cancer treatment,
immunotherapy,
bladder cancer,
combination therapy
People
Edward Gelmann
Co-Investigator (COI)
Medicine
﹒Professor
